The antiinfective medicine sales in Australia are forecasted to grow steadily from 2024 to 2028, starting from $1.24 billion USD PPP in 2024 and reaching $1.34 billion USD PPP by 2028. In 2023, the actual sales stood at $1.22 billion USD PPP. The year-on-year variation shows a consistent growth trend of approximately 1.6% annually. Over the last two years, the year-on-year growth has been in the range of 1.5% to 2%, reflecting a stable market expansion. The compound annual growth rate (CAGR) over the next five years is roughly 1.6%.
Future trends to watch for include:
- Advancements in antimicrobial resistance technologies
- Increased governmental and healthcare funding
- Rising demand for over-the-counter antiinfective medicines
- Population growth and ageing which may drive higher demand
